info@seagull-health.com
SeagullHealth
语言:
search
new
Dietary precautions for patients with Vadadustat
511
Article source: Seagull Pharmacy
Sep 29, 2026

Vadadustat is an oral treatment for anemia of chronic kidney disease, and diet and medication timing directly affect efficacy and safety, requiring special attention.

1. Basic Relationship Between Medication and Food

1. May Be Taken With or Without Food

Vadadustat may be taken with or without food, and a high-fat meal has no clinically significant effect on drug absorption.

Patients do not need to adjust medication timing based on food intake and may take it at a fixed time according to daily habits.

It is recommended to take the medication at approximately the same time each day to maintain stable blood drug concentrations.

2. Tablets Must Be Swallowed Whole

Tablets should be swallowed whole and must not be cut, crushed, or chewed.

They may be taken with warm water, avoiding changes in absorption caused by breaking the tablet.

2. Dosing Interval With Iron Supplements and Iron-Containing Products

1. Iron Supplements and Iron-Containing Products Must Be Staggered

Oral iron supplements, iron-containing products, and iron-containing phosphate binders reduce vadadustat exposure and may weaken efficacy.

Vadadustat should be taken at least 1 hour before the above products.

Common iron-containing products include iron supplements and iron-containing phosphate binders, and patients should proactively inform their doctor of the types they are using.

2. Interval Requirements for Non-Iron-Containing Phosphate Binders

Non-iron-containing phosphate binders also affect vadadustat absorption.

Vadadustat should be taken at least 1 hour before or at least 2 hours after non-iron-containing phosphate binders.

Common non-iron-containing phosphate binders include calcium acetate, sevelamer carbonate, and others.

3. Overall Management of Phosphate Binders

Dialysis patients often need phosphate binders to control serum phosphorus, and these must be taken separately from vadadustat.

Patients are advised to establish a fixed daily medication order to avoid missed doses or taking medications at the same time.

If unsure whether a product contains iron, consult a doctor or pharmacist.

3. Other Dietary and Medication-Related Precautions

1. Alcohol and Smoking

Patients with a history of gastrointestinal erosion, peptic ulcer, smoking, or alcohol use have a higher risk of gastrointestinal erosion.

Smoking cessation and alcohol restriction are recommended to reduce the risk of gastric and esophageal mucosal injury.

If abdominal pain, black stools, or vomiting blood occurs, seek medical attention immediately.

2. Dietary Reminders for Concomitant Medications

Vadadustat may increase exposure to some statins, and adverse reactions should be monitored during concomitant use.

When used with simvastatin, the daily dose should not exceed 20 mg; when used with rosuvastatin, the daily dose should not exceed 5 mg.

During statin use, avoid drinking large amounts of grapefruit juice to prevent further increases in drug concentrations.

3. Blood Pressure and Fluid Management

Vadadustat may worsen hypertension and may even cause hypertensive crisis.

Patients should monitor blood pressure regularly and take antihypertensive medications as prescribed.

Dialysis patients need to control fluid and sodium intake to avoid blood pressure fluctuations.

4. Nutrition and Anemia Management

Other causes of anemia, such as vitamin deficiency and bleeding, should be corrected before treatment.

Iron status should be assessed during treatment, and iron supplements should be given when necessary.

Ensure adequate intake of high-quality protein and vitamins, but individualized adjustment is needed in accordance with renal diet requirements.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Vadadustat(Vafseo)
Vadadustat(Vafseo)
Treatment of anemia in adults with chronic kidney disease (CKD) who have been...
WeChat Scan
Free Inquiry
Recommended Articles
Special population medication for Vadadustat
Vadadustat is used in adults with anemia of chronic kidney disease who have been on dialysis for at least 3 months, and use in special populations requires careful assessment of risks and benefits.1. ...
Adverse reactions of Infigratinib
Infigratinib is used to treat cholangiocarcinoma with FGFR2 fusion or rearrangement, and its adverse reactions involve multiple systems. Key monitoring areas include ocular effects, phosphate metaboli...
Dietary habits of Infiglatinib patients
Infigratinib must be taken on an empty stomach, and food can significantly affect its absorption. Patients should understand the timing of dosing and meals, and avoid certain foods and gastric acid-re...
Special population use of Infiglatinib
Infigratinib is used to treat cholangiocarcinoma with FGFR2 fusion or rearrangement. Dosing in special populations requires individualized adjustment based on factors such as hepatic and renal functio...
Side effects of Vadadustat
Vadadustat is used for anemia of chronic kidney disease in dialysis patients and may cause multiple types of adverse reactions involving the cardiovascular, hepatic, and gastrointestinal systems, requ...
Special population medication for Bylvay
Odevixibat is an ileal bile acid transporter (IBAT) inhibitor used to treat pruritus associated with progressive familial intrahepatic cholestasis (PFIC) and Alagille syndrome (ALGS).I. Use in Pregnan...
Dietary precautions for patients with Bylvay
Odevixibat is used to treat pruritus in patients with PFIC and ALGS. Its absorption and efficacy are affected by diet, and it may interfere with the absorption of fat-soluble vitamins. Patients should...
Side effects of Odevixibat
Odevixibat is used to treat pruritus associated with PFIC and ALGS. Its side effects mainly involve the liver, gastrointestinal tract, and fat-soluble vitamin absorption, requiring focused monitoring ...
Related Articles
Side effects of Vadadustat
Vadadustat is used for anemia of chronic kidney disease in dialysis patients and may cause multiple types of adverse reactions involving the cardiovascular, hepatic, and gastrointestinal systems, requ...
Dietary precautions for patients with Vadadustat
Vadadustat is an oral treatment for anemia of chronic kidney disease, and diet and medication timing directly affect efficacy and safety, requiring special attention.1. Basic Relationship Between Medi...
Special population medication for Vadadustat
Vadadustat is used in adults with anemia of chronic kidney disease who have been on dialysis for at least 3 months, and use in special populations requires careful assessment of risks and benefits.1. ...
Storage environment for Vadadustat
The storage of vadadustat requires attention to temperature, packaging, and storage safety, and proper storage can ensure stable drug efficacy. The following is explained from three aspects: temperatu...
Precautions for the use of Vadadustat
Vadadustat is used for anemia in adults with chronic kidney disease who have been on dialysis for at least three months, and its use requires vigilance for risks such as thrombosis, liver injury, and ...
Side effects and adverse reactions of Vadadustat
Vadadustat is used for anemia in chronic kidney disease patients on dialysis, but it may cause serious adverse reactions such as thrombosis, liver injury, and increased blood pressure, requiring close...
How to Use Vadadustat (Vafseo)
Vadadustat (Vafseo) is a hypoxia-inducible factor prolyl hydroxylase (HIFPH) inhibitor, indicated for the treatment of anemia associated with chronic kidney disease (CKD) in adults who have been recei...
Indications for Vadadustat (Vafseo)
Vadadustat (Vafseo) is a hypoxia-inducible factor prolyl hydroxylase (HIFPH) inhibitor, used for the treatment of anemia caused by chronic kidney disease (CKD).Indications for Vadadustat (Vafseo)Indic...
New Drugs
Cenobamate(Xcopri)
Cenobamate(Xcopri)
It is used for the treatment of partial-onset seizures in adults (with or...
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • haiousales@gmail.com
Welcome to consult
Seagull Pharmacy.,Ltd All rights reserved